Biogen, Inc. (BIIB)
218.11
+1.33
(+0.61%)
USD |
NASDAQ |
Aug 24, 16:00
218.11
0.00 (0.00%)
After-Hours: 19:58
Biogen Market Cap : 32.21B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 32.02B |
| August 20, 2026 | 31.66B |
| August 19, 2026 | 32.72B |
| August 18, 2026 | 31.39B |
| August 17, 2026 | 30.89B |
| August 14, 2026 | 30.99B |
| August 13, 2026 | 31.11B |
| August 12, 2026 | 30.85B |
| August 11, 2026 | 30.11B |
| August 10, 2026 | 30.59B |
| August 07, 2026 | 30.71B |
| August 06, 2026 | 30.47B |
| August 05, 2026 | 30.52B |
| August 04, 2026 | 30.79B |
| August 03, 2026 | 29.81B |
| July 31, 2026 | 29.98B |
| July 30, 2026 | 30.71B |
| July 29, 2026 | 30.90B |
| July 28, 2026 | 30.37B |
| July 27, 2026 | 29.56B |
| July 24, 2026 | 29.86B |
| July 23, 2026 | 29.61B |
| July 22, 2026 | 29.19B |
| July 21, 2026 | 29.99B |
| July 20, 2026 | 29.51B |
| Date | Value |
|---|---|
| July 17, 2026 | 30.40B |
| July 16, 2026 | 30.84B |
| July 15, 2026 | 29.11B |
| July 14, 2026 | 28.33B |
| July 13, 2026 | 30.85B |
| July 10, 2026 | 29.39B |
| July 09, 2026 | 29.36B |
| July 08, 2026 | 29.57B |
| July 07, 2026 | 30.36B |
| July 06, 2026 | 30.77B |
| July 02, 2026 | 31.90B |
| July 01, 2026 | 30.96B |
| June 30, 2026 | 31.89B |
| June 29, 2026 | 31.97B |
| June 26, 2026 | 31.89B |
| June 25, 2026 | 29.81B |
| June 24, 2026 | 29.46B |
| June 23, 2026 | 29.11B |
| June 22, 2026 | 29.48B |
| June 18, 2026 | 29.02B |
| June 17, 2026 | 29.32B |
| June 16, 2026 | 28.87B |
| June 15, 2026 | 29.32B |
| June 12, 2026 | 29.53B |
| June 11, 2026 | 29.51B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ionis Pharmaceuticals, Inc. | 10.27B |
| AbbVie, Inc. | 467.37B |
| Gilead Sciences, Inc. | 182.13B |
| Vertex Pharmaceuticals, Inc. | 138.77B |
| Amgen, Inc. | 239.94B |
Market Cap Related Metrics
| PE Ratio | 38.63 |
| PS Ratio | 3.335 |
| Price to Book Value | 1.709 |
| Price to Free Cash Flow | 12.94 |
| Price | 218.11 |
| Earnings Yield | 2.59% |
| Operating PE Ratio | 17.11 |
| Normalized PE Ratio | 23.87 |